074430 — AMINOLOGICS CO Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for AMINOLOGICS CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	22,849	27,337	20,887	16,790	22,020
Cost of Revenue
Gross Profit	9,135	12,808	7,776	3,419	9,860
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	20,278	33,820	19,425	19,929	19,484
Operating Profit	2,571	-6,483	1,462	-3,139	2,536
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,704	-6,281	2,291	-1,105	3,515
Provision for Income Taxes
Net Income After Taxes	5,360	-7,282	2,436	-1,620	3,522
Net Income Before Extraordinary Items
Net Income	5,360	-7,282	2,436	-1,620	3,522
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5,360	-7,282	2,436	-1,620	3,522
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	72.4	17.1	27.7	-11.2	47.9
Dividends per Share